Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2024-03-29 00:00:00 ET · period of report 2024-03-28 · accession 0001062993-24-007462 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-29 | 2024-03-28 | ORGO | Bilbo Patrick | COO | M - OptEx | $1.18 | +152.2K | 811.6K | +23% | +$179.7K |
| D | 2024-03-29 | 2024-03-28 | ORGO | Bilbo Patrick | COO | M - OptEx | $0.00 | -152.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-03-28 | M | A | 152,250 | $1.18 | 811,579 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-03-28 | M | D | 152,250 | $0.00 | 0 | D | $1.18 · — to 2024-04-10 | 152,250 Class A Common Stock | (F1) 100% of the shares subject to this option are fully vested and exercisable. |